Literature DB >> 8647076

Sequence-specific resonance assignments of the 1H-NMR spectra and structural characterization in solution of the HIV-1 transframe protein p6.

M Beissinger1, C Paulus, P Bayer, H Wolf, P Rösch, R Wagner.   

Abstract

The frameshift protein p6* encoded directly upstream of the protease in the human immunodeficiency virus type 1 (HIV-1) pol reading frame is thought to be a natural inhibitor of protease activation and to play a role in the polyprotein processing of Gag and Gag-Pol precursors. To allow structural characterization of the p6* transframe protein, the p6* coding region was cloned into the vector pGEX-KG and expressed in Escherichia coli as a fusion protein with glutathione S-transferase (GST) under the control of the tac promoter. Thrombin cleavage of the construct resulted in a 70-amino-acid polypeptide which is extended by two additional residues at the N-terminus compared to the natural p6* sequence. The native purification procedure including an affinity and a size-exclusion chromatography step yielded sufficient amounts of highly pure protein suitable for NMR spectroscopy. Fluorescence, circular dichroism and 1H-NMR spectroscopy were applied to characterize the structure of protein. Two-dimensional NMR spectra provided essentially complete sequence-specific resonance assignments at pH 5.9. Although there is evidence for a helix-forming tendency in the N-terminus of the protein, the experiments indicate that p6* has no overall stable secondary or tertiary structure with the single tryptophan exposed in aqueous solution. However, the results reported herein open the way to characterize further the interaction of p6* with the HIV-1 protease in structural and functional in vitro studies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647076     DOI: 10.1111/j.1432-1033.1996.0383k.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

1.  Effect of the active site D25N mutation on the structure, stability, and ligand binding of the mature HIV-1 protease.

Authors:  Jane M Sayer; Fengling Liu; Rieko Ishima; Irene T Weber; John M Louis
Journal:  J Biol Chem       Date:  2008-02-15       Impact factor: 5.157

2.  Uncoupling human immunodeficiency virus type 1 Gag and Pol reading frames: role of the transframe protein p6* in viral replication.

Authors:  Andreas Leiherer; Christine Ludwig; Ralf Wagner
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

3.  Terminal interface conformations modulate dimer stability prior to amino terminal autoprocessing of HIV-1 protease.

Authors:  Johnson Agniswamy; Jane M Sayer; Irene T Weber; John M Louis
Journal:  Biochemistry       Date:  2012-01-24       Impact factor: 3.162

Review 4.  Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.

Authors:  Bin Xue; Marcin J Mizianty; Lukasz Kurgan; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2011-10-28       Impact factor: 9.261

5.  Proline residues within spacer peptide p1 are important for human immunodeficiency virus type 1 infectivity, protein processing, and genomic RNA dimer stability.

Authors:  Melissa K Hill; Miranda Shehu-Xhilaga; Suzanne M Crowe; Johnson Mak
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  Cleavage of human immunodeficiency virus type 1 proteinase from the N-terminally adjacent p6* protein is essential for efficient Gag polyprotein processing and viral infectivity.

Authors:  U Tessmer; H G Kräusslich
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  Human immunodeficiency virus (HIV) type 1 transframe protein can restore activity to a dimerization-deficient HIV protease variant.

Authors:  Nathalie Dautin; Gouzel Karimova; Daniel Ladant
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  Interactions between SIVNef, SIVGagPol and Alix correlate with viral replication and progression to AIDS in rhesus macaques.

Authors:  Luciana Jesus da Costa; Adriana Lopes Dos Santos; Robert Mandic; Karen Shaw; Renato Santana de Aguiar; Amilcar Tanuri; Paul A Luciw; B Matija Peterlin
Journal:  Virology       Date:  2009-09-11       Impact factor: 3.616

9.  Efavirenz enhances HIV-1 gag processing at the plasma membrane through Gag-Pol dimerization.

Authors:  Sho Sudo; Hiyori Haraguchi; Yoko Hirai; Hiroyuki Gatanaga; Jun-ichi Sakuragi; Fumitaka Momose; Yuko Morikawa
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

10.  Importance of protease cleavage sites within and flanking human immunodeficiency virus type 1 transframe protein p6* for spatiotemporal regulation of protease activation.

Authors:  Christine Ludwig; Andreas Leiherer; Ralf Wagner
Journal:  J Virol       Date:  2008-03-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.